- DeJonge Associates has developed a new tablet dispenser that can be used to make prescription drugs available in a controlled, timely manner that closely follows the doctor’s orders. This tablet dispenser is designed to reduce the growing opioid addication crisis. Many people have become addicted to opioids due to careless mis-dosing or overuse. This dispenser design - available at the pharmacy with a deposit - controls availability of medication and reduces potential for overuse.
- Read our News Release about the new locked, controlled timed-dose tablet dispenser.
- Ergonomics and Compliance: This article looks at package compliance considerations such as design and labeling, from the patient's point of view.
- Packaging Developments of 2018: materials, anti-counterfeiting, package integrity and logistics developments.
- Double Safe is our New CR Closure Design: Some products are extremely toxic. Other products may be very attractive to children. In these cases a standard Child Resistant (CR) closure may not be sufficient. This is why we created Double Safe.
- Packaging Innovations Help Pharma Overcome Challenges: This article describes the balance required to ensure packaging is safe, functional, supportive and sustainable.
- Packaging Trends for 2018: This article sourced from 99designs discusses colors, shapes and graphic design trends for packaging design in 2018.
- New Packaging Regulations for Europe and Beyond This article from Packaging Digest desribes how DuPont has been gathering a lot of packaging data via extensive Medical Packaging Transition Project (MPTP) studies.
- Things to Consider for Child-Resistant Packaging. This short list provides a quick comparison of child-resistant (CR) and adult compatibility ranges. DeJonge Associates have a variety of CR package solutions that are compatible across age ranges.
- Blister Packaging Market worth 18.25 Billion USD by 2022. In response to overall growth in the healthcare sector, the market for blister packaging is expected to continue growing. Blister packaging helps protect products from moisture and light and extends shelf life. DeJonge Associates have a variety of specialized blister package solutions, including CR (child-resistant) applications.
- Packaging is more important then ever to consumers. A new study of U.S. consumers shows that packaging is very or extremely important to their satisfaction with products. Meanwhile, the relative importance of other factors such as product quality, price, convenience, and brand have stayed constant or declined over the same period.
- Consumer Emotional Responses to Protective Packaging: Data shows that the experience of opening packages, removing products from the package and discarding the package can impact future purchases.
- The FDA is warning about eye drop bottles that have loose plastic safety seals or tamper-evident rings below the bottle cap that may fall onto the eye when the product is used.
- Pharmaceutical Packaging Market Continues to Grow: World demand for pharmaceutical packaging is expected to increase 6.5 percent annually to over $101 billion in 2019. The increased demand for pharmaceutical packaging will be spread among developed economies with additional growth among developing economies in Asia, Africa and South America.
- Quality, then Cost: "The economy is straining packaging budgets, but packaging engineers report that maintaining quality is still more important than cost cutting," reports Pharmaceutical and Medical Packaging News.
- The FDA has issued new guidelines for the development and labeling of abuse-deterrent opioid drugs. The guidelines describe how studies should be performed and evaluated, and what labeling claims may be approved.
- What technologies will transform pharmaceutical packaging over the next five years? 3D printing, cloud computing and the Internet of Things are predicted to have the greatest potential to transform packaging as we know it. This link shows one example of packaging that is already utilizing an internet connection for HIV/AIDS medication adherence.
- Global bioplastics production is expected to grow 400% by 2018. Bio-based but non-biodegradable plastics are showing the most growth. Globally, flexible and rigid packaging applications are the leading uses of bioplastics.
- The FDA is supporting training to help students and entreprenuers design, test and evaluate innovative medical devices. The National Medical Device Curriculum is in place at several universities, but the curriculum is free and available via the FDA website.
- What types of pharmaceutical containers are forecasted for growth in coming years? Interestingly, plastic bottles, blister packs and dispensing closures are predicted to remain as staples of the industry, with particluar growth in the plastic bottle segment. At DeJonge Associates we have a variety of CR blister packs, bottle and closure designs available for licensing or contract production.
- The US pharmaceutical packaging market is growing, especially in the categories of plastic bottles and child-resistant containers, both of which are specialization areas for DeJonge & Associates. Many of our innovative plastic bottles for pharmaceuticals are child-resistant by their inherent design or can be fitted with our unique CR cap systems.
- New regulations in the UK and Europe will require child-resistant packaging for any products which present an aspiration hazard from fumes, or those that can cause skin or eye damage if splashed, or are toxic if swallowed, including products such as soluble dishwasher tabs.
- This article from packworld.com makes a claim we'd agree with: "Increasingly, the answer to the question of what makes a pharmaceutical product safe is, 'Its packaging'.”
- DeJonge Associates was recently granted pharmaceutical packaging patents for our CR Overcap for Pump Sprayers, Bottom Lift, and our CR Overcap for Pump Sprayers Twist Lock. See the illustrations and patent information at the links.
- Child-resistant packaging laws are becoming more restrictive worldwide, and for a variety of reasons. This article discusses the pros, cons and marketing considerations of CR packaging, and the recent CPSC ruling on imidazolines here in the US.
- DeJonge Associates was recently granted another pharmaceutical packaging patent for our CR Overcap for Pump Sprayers. See the illustrations and patent information at the link.
- At DeJonge Associates we have different container designs that address the requirements of the Consumer Product Safety Comission rules regarding imidazolines and child-resistant (CR) packaging. See our CR Squeeze Cap for Small Bottles and our CR Closure for Small Containers. These CR packages work well for eye drops or nasal sprays.
- We've added three new patents to our Package Gallery: The Metered Dispenser with Feed consistently and precisely dispenses a predetermined dosage of liquid, and reduces the risk of contamination. The Rectangular Metered Dispenser with Feed has the same features, but is adapted for rectangular packaging. The Screw-Type Metered Dispenser also offers the same functionality but utilizes a different mechanism.
- This article about Millennials and Package Design makes several good points about satisfying this fickle group of consumers. We would add only one more point: simplicity and ease of use are important to individuals in every user group.
- Here's a link to the patent page for our Metered Dose Squeeze Dispenser. The patent page provides detailed drawings and descriptions that describe how the container delivers such precise amounts of medication or other liquids.
- Samples of our popular Precision Metered Liquid Dispenser are still available. This product can be specifically designed to meet concerns raised in the FDA's Guidance for Industry report: Dosage Delivery Devices for Orally Ingested OTC Liquid Drug Products.
- More on prescription compliance: The link below leads to an article that discusses prescription non-compliance in human terms, specifically in regard to deaths and hospital re-admission, and the financial impact on patients and programs like Medicare. Most interesting are some of the novel ideas on packaging and increasing prescription adherence.
- There are lots of good reasons to encourage prescription compliance, the first being a patient's health. This article takes the industry economics into account and explains the supportive role that packaging can play in encouraging prescription adherence and compliance.
Samples of our precision metered dose liquid dispenser are now available. This patented design allows only a metered amount of liquid to flow from a dispensing container, but permits varying amounts when measured to lines on the filling chamber. A key aspect of this design is that liquid can be precisely dispensed in any orientation, from horizontal to completely inverted.
Please email us at SDeJonge@PharmaPackagingDesign.com with your name and postal address to request a sample.
- Patient-focused innovations in pharmaceutical packaging will be the theme at the 2013 Pharmapack Europe trade show.
- Packaging designers and developers have a role to play in helping patients with dosage compliance and adherence. This article from the Journal of Patient Compliance examines data and industry efforts to address compliance challenges.
- This article on www.bizcommunity.com describes how simplicity and innovation in pharmaceutical packaging design helps to meet rapidly changing consumer trends and needs.
- This link leads to an interesting case study regarding a problem that required dessicant in a pharmaceutical container. We offer a different solution that works better with larger containers. See our dessicant basket for medication containers that keeps dessicants separate from the medication.
- From packworld.com: Considering sustainability in pharmaceutical package design can lead to new efficiencies, cost reductions, while providing good environmental stewardship.
- From healthcarepackaging.com: Inviting packaging to the product development process offers benefits ranging from package design to patient compliance to patent expiry.
- Consumer Product Safety Commission briefing package for proposed rulemaking for child-resistant packaging for products containing imidazolines.